Evidence map›Paper›PMID 35320288›Full record

ArticlePloS one2022

Quantification of histone H2AX phosphorylation in white blood cells induced by ex vivo gamma irradiation of whole blood by both flow cytometry and foci counting as a dose estimation in rapid triage.

Rujira Wanotayan, Sarinya Wongsanit, Kanokporn Boonsirichai, Kasama Sukapirom, Sakchai Buppaungkul, Putthiporn Charoenphun, Pucharee Songprakhon, Kulachart Jangpatarapongsa, Pimpon Uttayarat

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Determination of dose-response calibration curves for gamma radiation using gamma-H2AX immunofluorescence based biodosimetry.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2024
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Rujira WanotayanFaculty of Medical Technology, Department of Radiological Technology, Mahidol University, Nakhon Pathom, Thailand.ORCID 0000-0002-6844-2687
Sarinya WongsanitNuclear Technology Research and Development Center, Thailand Institute of Nuclear Technology (Public Organization), Ongkarak, Nakhon Nayok, Thailand.
Kanokporn BoonsirichaiNuclear Technology Research and Development Center, Thailand Institute of Nuclear Technology (Public Organization), Ongkarak, Nakhon Nayok, Thailand.ORCID 0000-0002-5706-3665
Kasama SukapiromFaculty of Medicine Siriraj Hospital, Siriraj Center of Research Excellence in Microparticle and Exosome in Diseases, Research Department, Bangkok, Thailand.
Sakchai BuppaungkulSecondary Standard Dosimetry Laboratory (SSDL), Bureau of Radiation and Medical Devices, Ministry of Public Health, Bangkok, Thailand.
Putthiporn CharoenphunFaculty of Medicine Ramathibodi Hospital, Division of Nuclear Medicine, Department of Diagnostic and Therapeutic Radiology, Mahidol University, Nakhon Pathom, Thailand.
Pucharee SongprakhonDivision of Molecular Medicine, Faculty of Medicine Siriraj Hospital, Research Department, Mahidol University, Bangkok, Thailand.
Kulachart JangpatarapongsaFaculty of Medical Technology, Center for Research and Innovation, Mahidol University, Nakhon Pathom, Thailand.
Pimpon UttayaratNuclear Technology Research and Development Center, Thailand Institute of Nuclear Technology (Public Organization), Ongkarak, Nakhon Nayok, Thailand.
Mahidol University · THSiriraj Hospital · THMinistry of Public Health · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A quick, reliable, and reproducible biological assay to distinguish individuals with possible life-threatening risk following radiological or nuclear incidents remains a quest in biodosimetry. In this paper, we examined the use of a γ-H2AX assay as an early dose estimation for rapid triage based on both flow cytometry and image analyses. In the experiment, whole blood from 11 donors was irradiated ex vivo inside a water phantom by gamma rays from Co-60 at 0.51 Gy/min. After the lysis of red blood cells, the white blood cells were collected for immunofluorescence labeling of γ-H2AX, CD45, and nuclear stained for signal collection and visualization. Analysis by flow cytometry showed that the relative γ-H2AX intensities of lymphocytes and granulocytes increased linearly with absorbed doses from 0 to 6 Gy with a large variation among individuals observed above 2 Gy. The relative γ-H2AX intensities of lymphocytes assessed by two different laboratories were highly correlated (ICC = 0.979). Using confocal microscopic images, γ-H2AX foci were observed to be discretely distributed inside the nuclei and to increase proportionally with doses from 0 to 2 Gy, whereas large plagues of merged foci appeared at 4 and 6 Gy, resulting in the saturation of foci counts above 4 Gy. The number of total foci per cell as well as the number of foci per plane were significantly different at 0 vs 1 and 2 vs 4 Gy doses (p < 0.01). Blind tests at 0.5 Gy and 1 Gy doses showed that dose estimation by flow cytometry had a mean absolute difference of less than 0.5 Gy from the actual value. In conclusion, while flow cytometry can provide a dose estimation with an uncertainty of 0.5 Gy at doses ≤ 1 Gy, foci counting can identify merged foci that are prominent at doses ≥ 4 Gy.

Indexed as

HistonesTriageDose-Response Relationship, RadiationFlow CytometryHumansLeukocytesLymphocytesPhosphorylationHistones

Identifiers

PMID35320288
PMCPMC8942256
OpenAlexW4220919861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.